IntroductionGranulation tissue formation is a consequence of chronic cellular immune responses associated with persistent infection or autoimmunity. Granulation tissue and chronic tissue fibrosis are formed and maintained by macrophages and other myelomonocytic cells 1-4 that produce cytokines such as interleukin 1 ␣ (IL-1␣). These cytokines are thought to increase fibroblast proliferation and collagen production which, in turn, induce tissue remodeling. [5][6][7][8][9] Although it is widely noted that fibrosis constitutes an important final stage of the chronic cellular immune response, and the contribution of T cells, macrophages, and fibroblasts has been documented, 10 the molecular mechanisms governing the interactions of these cells are still obscure.Macrophages and related cells are the predominant arm of cellular immunity involved with sensitization, inflammation, and tissue remodeling through cellular interactions and production of soluble factors. 11,12 The interactions of macrophages with extracellular milieu are mediated by a variety of cell surface recognition molecules including lectins, the carbohydrate-recognition proteins. Lectins expressed on these cells include galectins, particularly galectin-3; siglecs such as sialoadhesin; and many calcium-type (C-type) lectins. 13,14 These lectins are known to be involved in endocytosis, 15,16 cell adhesion, 17 and cellular trafficking. 18,19 The macrophage galactose-type calcium-type lectins (MGLs; CD301) constitute a unique class of C-type lectins because of their specificity for galactose and its structural homologues. 20,21 In mice, we have recently found that 2 closely related MGLs, termed MGL1 and MGL2 (CD301a and CD301b), have different carbohydrate specificity, though their distinct biologic roles are unknown. 21 MGLs/CD301 are type II transmembrane glycoproteins and are expressed on macrophages and related cells of myeloid origins, particularly immature dendritic cells (DCs). 22 Using a monoclonal antibody (mAb) reactive to both MGL1 and MGL2, these lectins were shown to be expressed on connective tissue macrophages, such as those in dermis, subdermic regions of skin, lamina propria in the gastrointestinal tract, bronchiole-associated connective tissues, perivascular regions in a variety of organs and tissues, and lymphoid organs. [23][24][25] Bone marrow-derived DCs and thioglycollateinduced peritoneal exudate cells were previously shown to express both MGL1 and MGL2. 21,22 However, the distribution of MGL1-positive cells and MGL1-negative cells within several organs seems to be distinct. For example, MGL1-positive/MGL2-positive cells and MGL1-positive/MGL2-negative cells but not MGL1-negative/MGL2-positive cells were present in dermis. MGL1, having a tyrosine internalization motif, was previously shown to be involved in endocytosis of galactoseterminated glycoconjugates in vitro. However, homozygous MGL1-deficient mice seemed to be healthy and immunologically competent as long as they were maintained under specific pathogen-free conditions. 21,26...